Search:   [Advanced]

Search Results

Search for "Atorvastatin" returned 30 results

previous12next

Showing 1-20 out of 30

DrugBank ID	Name	Formula	Weight
DB01076	Atorvastatin	C33H35FN2O5	558.6398
	Atorvastatin Atorvastatin, a selective, competitive HMG-CoA reductase inhibitor, is used to lower cholesterol and triglycerides in patients with hypercholesterolemia and mixed dyslipidemia and in ...
DB00559	Bosentan	C27H29N5O6S	551.6140
	... the anticoagulant effect Atorvastatin Bosentan could decrease atorvastatin effect Cerivastatin Bosentan could decrease the statin effect Cyclosporine Cyclosporine increases the effect and ...
DB00343	Diltiazem	C22H26N2O4S	414.5180
	... toxicity of diltiazem Atenolol Increased risk of bradycardia Atorvastatin Increases the effect and toxicity of atorvastatin Buspirone The calcium channel blocker increases the effect and ...
DB00238	Nevirapine	C15H14N4O	266.2979
	... effect Atazanavir Decreases levels/effect of atazanavir Atorvastatin The NNRT inhibitor increases the effect and toxicity of the statin Dicumarol Nevirapine decreases the anticoagulant effect ...
DB01241	Gemfibrozil	C15H22O3	250.3334
	... Anisindione Gemfibrozil increases the anticoagulant effect Atorvastatin Increased risk of myopathy/rhabdomyolysis Cerivastatin Increased risk of myopathy/rhabdomyolysis Dicumarol Gemfibrozil ...
DB02703	Fusidic Acid	C31H48O6	516.7092
	... inhibitor increases the effect and toxicity of fusidic acid Atorvastatin Increased risk of myopathy/rhabdomyolysis Fosamprenavir The protease inhibitor increases the effect and toxicity of ...
DB01039	Fenofibrate	C20H21ClO4	360.8310
	... Anisindione The fibrate increases the anticoagulant effect Atorvastatin Increased risk of myopathy/rhabdomyolysis Cerivastatin Increased risk of myopathy/rhabdomyolysis Dicumarol The fibrate ...
DB00619	Imatinib	C29H31N7O	493.6027
	... Aprepitant Aprepitant may change levels of chemotherapy agent Atorvastatin Increases the effect and toxicity of atorvastatin Carbamazepine Carbamazepine decreases levels of imatinib ...
DB01394	Colchicine	C22H25NO6	399.4370
	Atorvastatin Increased risk of rhabdomyolysis with this combination Cerivastatin Increased risk of rhabdomyolysis with this combination Clarithromycin Severe colchicine toxicity can occur ...
DB00625	Efavirenz	C14H9ClF3NO2	315.6750
	... Atazanavir Efavirenz decreases the levels/effects of atazanavir Atorvastatin The NNRT inhibitor increases the effect and toxicity of the statin Cisapride Increased risk of cardiotoxicity and ...
DB00224	Indinavir	C36H47N5O4	613.7895
	... Increased risk of hyperbilirubinemia with this association Atorvastatin Increases the effect and toxicity of atorvastatin Bismuth The antacid decreases the absorption of indinavir Calcium The ...
DB00705	Delavirdine	C22H28N6O3S	456.5610
	... Astemizole Increased risk of cardiotoxicity and arrhythmias Atorvastatin The NNRT inhibitor increases the effect and toxicity of the statin Bismuth The antiacid decreases the effect of ...
DB00196	Fluconazole	C13H12F2N6O	306.2708
	... of the tricyclic Anisindione Increases the anticoagulant effect Atorvastatin Increased risk of myopathy/rhabdomyolysis Carbamazepine Increases the effect of carbamazepine Celecoxib Increases ...
DB01149	Nefazodone	C25H32ClN5O2	470.0070
	... Astemizole Increased risk of cardiotoxicity and arrhythmias Atorvastatin Nefazodone increases the effect and toxicity of the statin drug Buspirone Nefazodone increases the effect of buspirone ...
DB01030	Topotecan	C23H23N3O5	421.4458
	Concomitant therapy should be avoided. Atorvastatin The p-glycoprotein inhibitor, Atorvastatin, may increase the bioavailability of oral Topotecan. A clinically significant effect is also expected ...
DB00615	Rifabutin	C46H62N4O11	847.0047
	... Atazanavir Atazanavir increases levels/toxicity of rifabutin Atorvastatin The rifamycin decreases the effect of the statin drug Atovaquone Rifabutin decreases the effect of atovaquone ...
DB00701	Amprenavir	C25H35N3O6S	505.6270
	... Astemizole Increased risk of cardiotoxicity and arrhythmias Atorvastatin Amprenavir can possibly increase the statin toxicity Bepridil Increases the effect and toxicity of bepridil Bismuth ...
DB01319	Fosamprenavir	C25H36N3O9PS	585.6070
	... Astemizole Increased risk of cardiotoxicity and arrhythmias Atorvastatin Amprenavir can possibly increase the statin toxicity Bepridil Amprenavir increases the effect and toxicity of bepridil ...
DB00220	Nelfinavir	C32H45N3O4S	567.7820
	... Astemizole Increased risk of cardiotoxicity and arrhythmias Atorvastatin Nelfinavir increases the effect and toxicity of the statin Chlordiazepoxide The protease inhibitor increases the effect ...
DB00564	Carbamazepine	C15H12N2O	236.2686
	... of aprepitant Aripiprazole Decreases the effect of aripiprazole Atorvastatin Decreases the effect of the statin Atracurium Decreases the effect of muscle relaxant Bupropion Decreases the ...

Showing 1-20 out of 30

previous12next

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.